How to Induce a Fever: The Science and Medical Uses

Fever has been deliberately induced for medical purposes for well over a century, and the practice continues today in refined forms ranging from whole-body hyperthermia for cancer and depression to controlled endotoxin challenges in research labs. The idea sounds counterintuitive: fever is something most people reach for ibuprofen to get rid of. But the immune and physiological changes that accompany a rise in core body temperature have real therapeutic potential, and understanding how and why clinicians raise body temperature on purpose sheds light on what fever actually does for us when it happens naturally.

What Fever Actually Is, and Why the Distinction Matters

Before talking about inducing fever, it helps to know what separates fever from other kinds of overheating. In fever, your brain’s thermostat actively resets to a higher target temperature. You shiver and seek warmth to reach that new set point, and fever-reducing drugs like aspirin can bring it back down because they act on the chemical signal that shifted the set point in the first place. No other type of elevated body temperature works this way. Heatstroke, for instance, is an unregulated rise where the body’s cooling mechanisms are overwhelmed rather than deliberately overridden.¹

The chemical that resets the thermostat is prostaglandin E2 (PGE2). When immune cells detect an infection, they release signaling molecules called cytokines, particularly interleukin-1, interleukin-6, and tumor necrosis factor-alpha.² These cytokines trigger PGE2 production near the brain. PGE2 then silences neurons in a region of the hypothalamus that normally keep your body temperature in check, and that silence releases the brakes on heat-generating circuits in the brainstem.³ The result is coordinated warming: blood vessels constrict, brown fat burns energy, muscles shiver. Your body actively drives its temperature upward, the same way a thermostat kicks on the furnace.

Interleukin-6 turns out to be especially important. Studies in mice lacking the gene for IL-6 showed that they could not develop a fever in response to tumor necrosis factor-alpha, even though normal mice mounted a clear febrile response. When IL-6 was injected directly into the brain of those deficient mice, fever was restored.⁴ This tells us that IL-6 acts centrally as a key link in the fever chain.

A Nobel Prize for Giving Patients Malaria

The most dramatic example of deliberate fever induction belongs to the early twentieth century. In an era before antibiotics, neurosyphilis (then called “general paresis of the insane”) was a progressive, fatal brain disease. Austrian psychiatrist Julius Wagner-Jauregg reasoned that inducing high fevers might kill the heat-sensitive syphilis bacterium in the brain. His solution was to infect patients with malaria. The repeated bouts of high fever worked well enough that malarial fever therapy became the worldwide standard treatment for neurosyphilis, and Wagner-Jauregg received the Nobel Prize in Medicine in 1927 for developing it.⁵⁶

Around the same time, a New York surgeon named William Coley was pursuing a different angle. He had noticed that some cancer patients who developed serious bacterial infections saw their tumors shrink. Coley developed a bacterial vaccine, known as Coley’s toxins, and used it to provoke intense fevers in patients with inoperable sarcomas. He achieved a cure rate of better than ten percent, remarkable for cancers that were otherwise untreatable at the time.⁷ His work was controversial and eventually sidelined by the rise of radiation therapy, but it planted the seed for modern cancer immunotherapy and hyperthermia research.

How Researchers Induce Fever Today

Modern researchers do not use malaria or crude bacterial vaccines. The standard experimental tool for triggering a fever-like inflammatory response in healthy volunteers is purified endotoxin, specifically lipopolysaccharide (LPS) derived from the outer membrane of certain bacteria. A standardized reference endotoxin, produced under NIH oversight, is injected intravenously in tiny doses. It reliably produces a temporary fever along with a cascade of immune activation that mirrors early stages of natural infection, including cytokine release, changes in blood cell counts, and shifts in hormone levels.⁸ This model is widely used to test anti-inflammatory drugs and to study how the immune system behaves during systemic inflammation.⁹

For therapeutic purposes rather than research, the tool of choice is controlled hyperthermia, which uses external heating rather than immune activation to raise body temperature. Whole-body hyperthermia (WBH) typically involves radiant heat devices, water-perfused blankets, or infrared systems that warm the body to a target temperature, often around 38.5 to 41.8°C depending on the clinical goal. Regional hyperthermia, used mainly in oncology, focuses heat on a specific tumor or body region using electromagnetic energy. The distinction matters: endotoxin induces a true fever with all the immune signaling that entails, while external heating raises temperature without necessarily triggering the same cytokine cascade.

Cancer Treatment and Targeted Heating

The most established modern use of induced hyperthermia is in cancer care. Heating a tumor to the range of 40 to 42°C causes several things that make other treatments work better. Blood flow and oxygen delivery to the tumor increase, which matters because many tumors are oxygen-starved in their cores, and both radiation and certain chemotherapy drugs work poorly without oxygen.¹⁰ The increased blood flow also improves delivery of chemotherapy drugs directly into the heated region.¹¹ Meanwhile, vascular permeability rises and the abnormal acidity common inside tumors shifts closer to normal, creating a less hospitable environment for cancer cells.

Randomized trials have established that regional hyperthermia combined with chemotherapy improves outcomes compared to chemotherapy alone in certain cancers.¹² The heat concentrates the chemotherapy effect within the tumor without increasing toxic side effects elsewhere in the body. However, whole-body hyperthermia for metastatic cancer is a different story. A review of the available studies found wide variation in response rates, ranging from about 12 to 89 percent across different cancers, and the absence of large randomized trials makes the added benefit of whole-body heating highly uncertain. Treatment-related deaths occurred in a small number of cases. Given the availability of less invasive options in modern oncology, whole-body hyperthermia for cancer is unlikely to become routine.¹³

There is an interesting wrinkle in the physics of tumor heating. When external power is applied, the rise in temperature provokes a rise in local blood flow, and that increased blood flow carries heat away, creating a feedback loop. Mathematical modeling suggests that once the external heating stops, temperature drops quickly, and blood flow falls in parallel.¹⁴ Tumors with impaired blood flow, paradoxically, may reach higher temperatures precisely because they are worse at dissipating heat.

Whole-Body Hyperthermia for Depression

One of the more surprising recent findings is that a single session of whole-body hyperthermia appears to reduce symptoms of major depression. In a randomized trial, participants who underwent active whole-body heating to about 38.5°C showed significantly lower depression scores compared to those who received a sham treatment, and the effect persisted for six weeks after the single session.¹⁵ The speed and duration of the response is noteworthy: many standard antidepressants take weeks to reach full effect, and here a single treatment was producing measurable improvements within a week that lasted over a month.

Follow-up work explored what might explain the antidepressant effect. Researchers found that whole-body hyperthermia caused a sharp spike in IL-6 immediately after treatment, and the size of that spike predicted how much depression scores improved in the following weeks. Larger acute IL-6 increases correlated with steeper drops in depressive symptoms.¹⁶ This is intriguing because IL-6 is the same cytokine that plays a central role in natural fever. Whether the antidepressant mechanism runs through immune signaling, direct effects of warmth on brain circuits, or some combination remains an open question. Published studies so far are limited by small sample sizes.¹⁷

What Fever Does for Your Immune System

The reason fever has been therapeutically useful across such different conditions comes down to what elevated temperature does to immune cells. Febrile temperatures boost a range of immune functions: neutrophils and monocytes become more mobile and better at engulfing pathogens, natural killer cells ramp up, and the production of type I interferons (which have direct antiviral activity) increases.¹⁸ Fever also makes rapidly dividing pathogens more vulnerable to destruction, especially in combination with other immune defenses like iron withholding.

A particularly elegant piece of the puzzle involves T cells, the adaptive immune cells that target specific threats. Research has shown that fever-range temperatures activate a heat-sensing pathway in T cells involving heat shock protein 90 (Hsp90), which binds to integrins on the T cell surface. This binding increases the cells’ ability to stick to blood vessel walls and migrate into infected tissues and lymph nodes, essentially helping T cells get to where they are needed faster.¹⁹ When this pathway was blocked experimentally, fever-enhanced T cell trafficking was abolished and bacterial clearance suffered. Heat shock proteins also play a broader role during fever: HSP70, for instance, acts as a molecular chaperone that helps regulate immune cell secretion of key signaling molecules during infection.²⁰

This raises an uncomfortable question about common practice. A study of volunteers infected with rhinovirus found that those who took aspirin or acetaminophen had suppressed antibody responses and increased nasal symptoms compared to those on placebo.²¹ There was also a trend toward longer virus shedding in the medicated groups. The finding does not mean you should never treat a fever, but it does suggest that reflexively suppressing every low-grade fever with over-the-counter drugs may sometimes work against the immune response the fever was designed to support.

The Safety Ceiling

If fever helps the immune system, why not push it higher? Because the body’s tolerance for elevated temperature has a hard ceiling, and the margin between “therapeutically useful” and “dangerous” is narrower than most people realize. Proteins in human cells begin to denature, meaning they lose their functional shape, at temperatures starting around 40°C. Even a relatively mild heat shock to 45°C causes an estimated four to seven percent of proteins to denature across most cellular compartments.²² At higher temperatures, cell membranes themselves become unstable, and the lipid bilayer and membrane-bound enzymes suffer damage that is likely the most significant cause of tissue death from heat.²³

Heatstroke, clinically defined by a core temperature above 40°C combined with nervous system dysfunction such as confusion, seizures, or coma, triggers a cascade of damage including oxidative stress, mitochondrial failure, and multiple forms of cell death throughout the body.²⁴ This is why clinical hyperthermia protocols are obsessively precise about temperature targets and monitoring. The therapeutic window for whole-body hyperthermia typically sits around 38.5 to 41.8°C for defined durations, and the boundary between that range and organ damage is not wide.

Natural fever rarely climbs to genuinely dangerous levels on its own. The brain’s thermoregulatory system imposes a ceiling, and fevers above 41°C from infection alone are unusual. The real danger comes from external heating, where temperature can continue rising without the built-in braking mechanism that infection-driven fever has.

Fever in Children and the Risk of Febrile Seizures

Fever’s safety profile changes meaningfully in young children. Febrile seizures, which typically affect children between about three months and five years of age, are the most common type of seizure in that age group.²⁵ They occur when fever causes a rapid increase in core temperature, leading to abnormal neuronal excitability. The mechanism involves the same cytokines that drive fever: IL-1β in particular can increase excitatory signaling in the brain while decreasing inhibitory signaling, tipping the balance toward seizure activity.²⁶

Simple febrile seizures, while terrifying for parents, are generally brief and benign. But prolonged febrile seizures can have lasting effects on brain excitability, and this is one reason any deliberate attempt to raise body temperature has no place in pediatric self-care. The vulnerability of the developing brain to temperature spikes is a biological reality that limits any general advice about “letting a fever run its course.”

The Metabolic Price of Running Hot

Fever is not free. Maintaining an elevated body temperature requires extra energy. Research in children on total parenteral nutrition, where energy intake could be precisely measured, found that energy expenditure rose by roughly 11 percent for each degree Celsius of fever.²⁷ A two-degree fever, then, costs the body about a quarter more energy than baseline. In someone who is already sick, malnourished, or critically ill, this metabolic tax is not trivial. It helps explain why prolonged high fevers leave people feeling exhausted, and why there is a genuine trade-off between the immune benefits of fever and the energetic cost of sustaining it.

Behavioral Fever in Cold-Blooded Animals

One of the strongest arguments that fever is not just a byproduct of infection but a genuine survival strategy comes from animals that cannot generate their own body heat. Fish, reptiles, and amphibians cannot shiver or burn brown fat to warm up, but when infected, many of them seek warmer environments. This “behavioral fever” raises their body temperature by the same few degrees that internal fever raises ours, and it improves their survival.²⁸ The underlying mechanisms, including the role of cytokines and prostaglandins, are shared between mammals and these cold-blooded vertebrates.

Recent research has gone further, showing that behavioral fever in fish optimizes T cell function by reducing T cell death during infection. The coupling of fever with adaptive immunity appears to be an ancient strategy that predates the split between cold-blooded and warm-blooded vertebrates.²⁹ Fever is not a quirk of mammalian biology. It is deeply conserved across hundreds of millions of years of evolution, which suggests the survival benefit has consistently outweighed the metabolic cost.

Psychogenic Fever and Stress-Induced Warming

Not all induced temperature rises come from infection or external heating. Some people experience genuine, measurable increases in core body temperature from psychological stress alone. This phenomenon, called psychogenic fever, operates through a different pathway than infection-driven fever. Rather than working through cytokines and prostaglandin E2, stress-induced hyperthermia involves the sympathetic nervous system, with a key role played by brown adipose tissue generating heat in response to stress hormones.³⁰

A telling case report documented a patient with psychogenic fever whose core temperature rose measurably during a stress interview. Blood tests showed no increase in the pyrogenic cytokines that drive infectious fever, confirming that the temperature rise was not mediated by the standard fever pathway but was instead an active, brain-controlled warming process.³¹ This distinction matters clinically because standard fever-reducing drugs like aspirin, which block prostaglandin synthesis, do not work on psychogenic fever. Treating the underlying stress or anxiety is the only way to resolve it. Psychogenic fever remains underrecognized in clinical practice, and patients sometimes undergo extensive infectious workups before the psychological origin is identified.